Predictors of Occult Atrial Fibrillation in 171 Patients With Cryptogenic TIA and Minor Stroke

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03166969

Acronym

HOLTER-21J

Enrollment

171

Registered

2017-05-25

Start date

2007-02-28

Completion date

2013-01-31

Last updated

2017-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryptogenic Transient Ischemic Attack and Minor Stroke

Brief summary

Retrospective study, single-center, on 171 patients, presented a cryptogenic TIA and Minor stroke. This study objective is to determine profitability of Holter 21 days for screening paroxystic ACFA / flutter in cryptogenic TIA/Minor stroke, and identify the predictive factors of discovery a paroxystic ACFA on Holter 21 days. Clinical and échocardiographics factors, and brain imaging (scanner and MRI) will be analyzed.

Interventions

PROCEDUREHolter 21 days

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Cryptogenic TIA/Minor stroke * Age \> 18 years * Medical care in Neuro Vascular Unit of CH Versailles * Holter 21 days performed

Exclusion criteria

1. ACFA history 2. ECG or telemetry who showed ACFA before the Holter initializing 3. Carotid Stenosis / symptomatic vertebral 4. Arterial dissection 5. Prothrombotic state demonstrated by laboratory tests 6. Infective endocarditis

Design outcomes

Primary

Measure	Time frame	Description
Number of atrial fibrillation detected on long duration ( 21 days) cardiac rythm holter monitoring	Day 21	Atrial fibrillation \>= 30 secondes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026